561 related articles for article (PubMed ID: 16961424)
1. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten AF
J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
[TBL] [Abstract][Full Text] [Related]
2. Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.
Brennan AR; Arnsten AF
Ann N Y Acad Sci; 2008; 1129():236-45. PubMed ID: 18591484
[TBL] [Abstract][Full Text] [Related]
3. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.
Arnsten AF; Li BM
Biol Psychiatry; 2005 Jun; 57(11):1377-84. PubMed ID: 15950011
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
Prince J
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
6. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
Arnsten AF
CNS Drugs; 2009; 23 Suppl 1():33-41. PubMed ID: 19621976
[TBL] [Abstract][Full Text] [Related]
7. Stimulants: Therapeutic actions in ADHD.
Arnsten AF
Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.
Arnsten AF; Pliszka SR
Pharmacol Biochem Behav; 2011 Aug; 99(2):211-6. PubMed ID: 21295057
[TBL] [Abstract][Full Text] [Related]
9. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
10. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of NSS in ADHD.
Pasini A; D'agati E
World J Biol Psychiatry; 2009; 10(4 Pt 2):495-502. PubMed ID: 19337883
[TBL] [Abstract][Full Text] [Related]
13. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
Castellanos FX; Acosta MT
Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
[TBL] [Abstract][Full Text] [Related]
14. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
Staller JA; Faraone SV
Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
[TBL] [Abstract][Full Text] [Related]
15. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
Levy F
Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
[TBL] [Abstract][Full Text] [Related]
16. Attention deficit hyperactivity disorder (ADHD): improved understanding and novel drug treatment.
Marsden CA
Neuropharmacology; 2009 Dec; 57(7-8):577-8. PubMed ID: 19733580
[No Abstract] [Full Text] [Related]
17. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.
Del Campo N; Chamberlain SR; Sahakian BJ; Robbins TW
Biol Psychiatry; 2011 Jun; 69(12):e145-57. PubMed ID: 21550021
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
Stahl SM
J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
[No Abstract] [Full Text] [Related]
19. Psychostimulant treatment for ADHD is modulated by prefrontal cortex manipulation.
Tang A; Wanchoo SJ; Swann AC; Dafny N
Brain Res Bull; 2009 Dec; 80(6):353-8. PubMed ID: 19729055
[TBL] [Abstract][Full Text] [Related]
20. Right prefrontal brain activation due to Stroop interference is altered in attention-deficit hyperactivity disorder - A functional near-infrared spectroscopy study.
Jourdan Moser S; Cutini S; Weber P; Schroeter ML
Psychiatry Res; 2009 Sep; 173(3):190-5. PubMed ID: 19664910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
